All blog items

The School of Medicine Office for Faculty is pleased to announce the 2020 Duke Clinical Leadership Program (DCLP) fellows!

Research Community News iRIS/OnCore Updates DOCR News Recruitment Innovation Corner Training Opportunities Clinical Research Employee Highlights Partner Resources

Network leads clinical trials that address antibacterial resistance threats 

People with attention deficit hyperactivity disorder (ADHD) are more likely to self-administer nicotine and report more pleasurable responses than people without the condition, according to a study by Duke Health researchers.

Stefano Di Talia, assistant professor in the Department of Cell Biology, has been awarded the Shipley Foundation Award in Innovative Stem Cell Science. The award seeks to catalyze early-stage research with the potential to make significant strides in advancing human health.  Dr. Di Talia is one of only eight researchers nationwide to receive the award. 

Researchers have cleared a major obstacle in the development of an HIV vaccine, proving in animal models that effective, yet short-lasting antibodies can be coaxed into multiplying as a fighting force against the virus.

Research Community News iRIS/OnCore Updates DOCR News Recruitment Innovation Corner Did You Know? Training Opportunities Clinical Research Employee Highlights

Hoping to stay in the Triangle after graduation?  Keep your eye on Q2 Solutions, a leading clinical trial laboratory services organization. The Triangle Business Journal reports Q2, a joint venture of IQVIA and Quest Diagnostics, will create nearly 300 Triangle-based jobs between 2021 and 2022 followed by another 400 jobs by 2027.  The company currently has open positions in the Triangle and worldwide. https://www.q2labsolutions.com/

A heart transplant team at Duke University Hospital became the first in the U.S. to transplant an adult heart into a recipient through a process known as Donation after Circulatory Death, or DCD. Duke is one of five centers in the United States that has been approved to perform DCD heart transplants as part of a recently launched clinical trial of a device to circulate warm, oxygenated blood through organs.

Hoping to stay in the Triangle after graduation?  Keep your eye on Q2 Solutions, a leading clinical trial laboratory services organization. The Triangle Business Journal reports Q2, a joint venture of IQVIA and Quest Diagnostics, will create nearly 300 Triangle-based jobs between 2021 and 2022 followed by another 400 jobs by 2027.  The company currently has open positions in the Triangle and worldwide. https://www.q2labsolutions.com/